Results 161 to 170 of about 70,987 (344)

Marked attenuation of P63 expression in plasmacytoid urothelial carcinoma with expanded immunohistochemical framework including E‐cadherin, P120, HER2 and TRPS1

Histopathology, EarlyView.
Plasmacytoid urothelial carcinoma demonstrates marked attenuation of p63 expression together with frequent disruption of the E‐cadherin–p120 adhesion complex, supporting its characteristic discohesive growth pattern. Standardized HER2 scoring identifies a substantial positive subset, highlighting diagnostic pitfalls and potential therapeutic relevance ...
Busra Yaprak Bayrak, Kemal Kosemehmetoglu, Busra Ozbek, Sercan Simsek, Murat Oktay, Ganime Coban, Dilara Irem Arslan Kahraman, Egemen Akıncıoglu, Melek Buyukgok, Selin Colak, Hatice Nese Dogan, Burak Gurel, Selva Kabul, Kerem Karaca, Elif Ozsagir, Ece Ozturk, Havva Serap Toru, Gupse Turan, Nazif Alperen Yıldırım, Ozlem Nur Yıldız, Yasemin Yuyucu Karabulut, Liang Cheng, Mahmut Akgul   +22 more
wiley   +1 more source

SURVIVAL IN PATIENTS WITH HISTOLOGIC VARIANTS OF UROTHELIAL TYPE BLADDER CANCER

Jurnal Urologi Indonesia
Objective: This study aims to determine the life expectancy of patients with histologic variants in urothelial type bladder cancer and the highest or lowest mortality rate in Hasan Sadikin Academic Medical Centre.
Richard Hartanto, Sawkar Vijay Pramod
doaj   +1 more source

Simultaneous Occurrence of Urothelial Bladder Carcinoma and Primary Retroperitoneal Leiomyosarcoma [PDF]

, 2010
Ursula Herrmann, Avelino Hernandez, G. Hofmockel, Hubert G. W. Frohmüller   +3 more
openalex   +1 more source

Sequence Variants in PSMB8/PSMB9 Immunoproteasome Genes and Risk of Urothelial Bladder Carcinoma [PDF]

, 2023
Nasser A. Elhawary, Samar N Ekram, Iman S. Abumansour, Zohor Azher, Imad A. AlJahdali, Najiah M Alyamani, Hind M Naffadi, Ikhlas A. Sindi, Abdulaziz Baazeem, Anmar Nassir, Ahmad H. Mufti   +10 more
openalex   +1 more source

Dermatological Adverse Events Associated With Lapatinib Treatment in Dogs With Urothelial Carcinoma: A Retrospective Study

Veterinary Dermatology, EarlyView.
Lapatinib is widely used in human oncology; however, dermatological adverse events (DAEs) are common and have been correlated with treatment efficacy. In veterinary medicine, lapatinib use in combination with piroxicam has been shown to be effective in treating canine urothelial carcinoma (UC); however, the incidence and prognostic significance of DAEs
Kosuke Horita, Tomohiro Yonezawa, Yasuyuki Momoi, Shingo Maeda   +3 more
wiley   +1 more source

Invasive urothelial carcinoma of urinary bladder presenting with annular constriction and mimicking proctitis observed by colonoscopy

, 2021
Yuhong Liu, Ta‐Wei Pu, Hsing-Wei Yu, Jung‐Cheng Kang, Ching-Heng Yen, Chaoyang Chen   +5 more
openalex   +1 more source

Retracted: miR‐19a‐3p Promotes Tumor‐Relevant Behaviors in Bladder Urothelial Carcinoma via Targeting THBS1 [PDF]

, 2023
Computational and Mathematical Methods in Medicine
openalex   +1 more source

Cancer heterogeneity explored through immune cell deconvolution of the tumor microenvironment

Quantitative Biology, Volume 14, Issue 3, September 2026.
Abstract Cancer is a highly heterogeneous disease, characterized by significant variability across multiple dimensions. This diversity has been extensively studied from various perspectives. In this study, we aim to examine cancer heterogeneity through the lens of immune cell composition within the tumor microenvironment.
Limin Jiang, Chung‐I Li, Rui Xin, Jijun Tang, Yan Guo   +4 more
wiley   +1 more source

Enhancing urothelial carcinoma diagnosis with artificial intelligence–integrated urine cytology: Biopsy‐validated accuracy and efficiency gain

Cancer Cytopathology, Volume 134, Issue 6, June 2026.
Abstract Background Urine cytology is a noninvasive tool for detecting urothelial carcinoma, yet its performance depends heavily on expert cytologists and time‐intensive glass slide review. Artificial intelligence (AI)–assisted digital cytology has emerged as a potential solution to improve diagnostic sensitivity and workflow efficiency.
Sigfred Lajara, Jacqueline Cuda, Daniel L. Geisler, Caroline Staniszewski, Wei‐Lei Yang, Karen Atkison, Chih‐Yun Lin, Guowei Shao, Tien‐Jen Liu, Barbara Crothers, Rajiv Dhir, Samer N. Khader   +11 more
wiley   +1 more source

‘BJUI Clinical Dilemma’: Recurrent high‐grade non‐muscle‐invasive bladder cancer in 2026

BJU International, EarlyView.
Vignesh T. Packiam, Peter C. Black, James W. F. Catto, Saum Ghodoussipour, Max Kates, Ashish M. Kamat, Yair Lotan, Michael A. O’Donnell, Jeremy Y. C. Teoh, George N. Thalmann, Stephen B. Williams   +10 more
wiley   +1 more source